| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 0 | 490 | 3.240 | 8.501 | 9.822 | 1.166 | 2.792 | 8.883 | 14.147 | 8.192 |
| Total Income - EUR | 0 | 490 | 3.240 | 8.501 | 9.822 | 1.166 | 2.792 | 8.883 | 14.147 | 8.192 |
| Total Expenses - EUR | 0 | 972 | 1.654 | 6.343 | 8.072 | 2.840 | 5.748 | 4.236 | 11.641 | 10.052 |
| Gross Profit/Loss - EUR | 0 | -482 | 1.586 | 2.159 | 1.750 | -1.674 | -2.956 | 4.647 | 2.507 | -1.860 |
| Net Profit/Loss - EUR | 0 | -497 | 1.488 | 1.904 | 1.455 | -1.706 | -3.040 | 4.385 | 2.368 | -1.970 |
| Employees | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Herakles Medica Srl
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 4.640 | 4.593 | 4.515 | 4.432 | 4.346 | 4.264 | 0 | 0 | 0 | 0 |
| Current Assets | 34.942 | 34.757 | 35.673 | 36.674 | 37.382 | 34.928 | 29.216 | 29.210 | 28.871 | 27.559 |
| Inventories | 0 | 0 | 0 | 0 | 11 | 10 | 0 | 0 | 0 | 298 |
| Receivables | 34.839 | 34.469 | 33.977 | 35.258 | 36.217 | 33.239 | 26.836 | 22.275 | 20.968 | 24.649 |
| Cash | 103 | 288 | 1.696 | 1.416 | 1.154 | 1.679 | 2.380 | 6.935 | 7.902 | 2.612 |
| Shareholders Funds | 38.226 | 37.339 | 38.196 | 37.937 | 38.658 | 36.219 | 26.914 | 25.300 | 24.053 | 21.948 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 1.357 | 2.011 | 1.993 | 3.169 | 3.070 | 2.973 | 2.302 | 3.911 | 4.817 | 5.611 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8622 - 8622" | |||||||||
| CAEN Financial Year |
8622
|
|||||||||
Comments - Herakles Medica Srl